Skyrizi Prices, Coupons, Copay Cards & Patient Assistance
Skyrizi (risankizumab) is a member of the interleukin inhibitors drug class and is commonly used for Crohn's Disease, Plaque Psoriasis, Psoriasis, and others.
Skyrizi prices
Intravenous Solution
rzaa 60 mg/mL Skyrizi intravenous solution from $11,359.89 for 10 milliliters
| Quantity | Per unit | Price |
|---|---|---|
| 10 milliliters | $1,135.99 | $11,359.89 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Subcutaneous Solution
150 mg/mL Skyrizi subcutaneous solution from $23,904.83 for 1 milliliter(s)
| Quantity | Per unit | Price |
|---|---|---|
| 1 milliliter | $23,904.83 | $23,904.83 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
rzaa 180 mg/1.2 mL Skyrizi subcutaneous solution from $23,904.83 for 1.2 milliliters
| Quantity | Per unit | Price |
|---|---|---|
| 1.2 milliliters | $19,920.69 | $23,904.83 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
rzaa 360 mg/2.4 mL Skyrizi subcutaneous solution from $23,904.83 for 2.4 milliliters
| Quantity | Per unit | Price |
|---|---|---|
| 2.4 milliliters | $9,960.35 | $23,904.83 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Skyrizi Coupons, Copay Cards and Rebates
Skyrizi offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Skyrizi Complete Savings Card
Eligible commercially insured patients may pay as little as $5 per dose; annual maximum savings of $14,000 per calendar year.
- Applies to:
- Skyrizi
- Number of uses:
- Per prescription per calendar year
Form more information phone: 866-759-7494 or Visit website
Skyrizi Complete Savings Card Rebate
Eligible commercially insured patients may submit a rebate request if unable to use the Savings Card at the pharmacy; patient must pay in full for their dose in order to submit a rebate request; rebate may be submitted via fax, online or phone app.
- Applies to:
- Skyrizi
- Number of uses:
- One rebate per prescription fill
Form more information phone: 866-759-7494 or Visit website
Skyrizi Medicare Part D Extra Help Subsidy
Patients with Medicare Part D coverage may be eligible for the Extra Help Subsidy, which may lower premiums and prescription costs. Contact the program for more information.
- Applies to:
- Skyrizi
- Number of uses:
- Per prescription until program expires
Form more information phone: 800-772-1213 or Visit website
Patient Assistance & Copay Programs for Skyrizi
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Skyrizi (risankizumab-rzaa) Injection; Subcutaneous
More information please phone: 866-316-7263 Visit website
Provider: myAbbVie Assist for Skyrizi
Eligibility requirements:- Must be uninsured or underinsured
- At or below 400% of FPL
- Not applicable
- Must reside in the US and be under the direct care of a US physician
- Any patient who requires the medication and are in need should call the company. Eligibility determined on a case-by-case basis. Patients with prescription drug coverage may be eligible on exception basis. Contact program for details.
- Skyrizi (risankizumab-rzaa) Injection; Subcutaneous
More information please phone: 800-222-6885 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Otezla
Otezla (apremilast) is used to treat plaque psoriasis, psoriatic arthritis, and oral ulcers ...
Omvoh
Omvoh is used to treat moderate to severe ulcerative colitis or Crohn's disease in adults. This ...
Entyvio
Entyvio (vedolizumab) is used to treat ulcerative colitis (UC) and Crohn's disease, reducing ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Cosentyx
Cosentyx (secukinumab) is used to treat plaque psoriasis, psoriatic arthritis, ankylosing ...
Humira
Humira is a tumor necrosis factor blocker used to treat many inflammatory conditions in adults ...
Ilumya
Ilumya (tildrakizumab) is used to treat moderate-to-severe plaque psoriasis to reduce plaques ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Velsipity
Velsipity (etrasimod) is a medicine used to treat ulcerative colitis. Pfizer’s Velsipity improves u ...
More about Skyrizi (risankizumab)
- Check interactions
- Compare alternatives
- Reviews (64)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
- En español